Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
Irritable bowel syndrome (IBS) is a highly prevalent disorder of gut–brain interaction and poses a significant burden to patients. Pharmacotherapy, diet, and psychotherapy all have largely comparable clinical efficacy. Therefore, factors outside efficacy can have an important impact in determining p...
Main Authors: | Rosel Sturkenboom MD, PhD, Brigitte A B Essers PhD, Ad A M Masclee MD, PhD, Daniel Keszthelyi MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Journal of Patient Experience |
Online Access: | https://doi.org/10.1177/23743735221147762 |
Similar Items
-
Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome
by: Maryam Mosaffa-Jahromi PharmD, PhD, et al.
Published: (2017-01-01) -
The prevalence of Irritable Bowel Syndrome among high school pupile in Gorgan, North of Iran
by: Milad Fadai, et al.
Published: (2010-01-01) -
Physician modification of the Terumo Aortic TREO device for juxtarenal or pararenal aortic aneurysms
by: Eric Ducasse, MD, PhD, et al.
Published: (2024-06-01) -
Lichenified plaque in chin after chronic irritation
by: Doniya Milani, MS, et al.
Published: (2023-02-01) -
Gel immersion EMR of small-bowel inflammatory fibroid polyp using double-balloon endoscopy
by: Yuka Matsubara, MD, et al.
Published: (2024-02-01)